Developing design response spectra for Benghazi city including soil magnification effects
Building Engineering · 2024
DOI: 10.59400/be.v2i1.1190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Building Engineering, 2024. Verfasst von Fathi M. Layas und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Earthquakes in some countries worldwide cause loss of lives and properties. In Libya, the design of structures to resist earthquake forces was based on a paper published by Mallick in 1976. In 1977, and after small changes in the earthquake zoning map of Libya, the ministry of housing, at that time, adopted it as a draft code of practice for the design of structures to resist earthquake forces. With Benghazi city undergoing significant rehabilitation and development programs, including major national projects, there is a pressing need to estimate updated probabilistic seismic hazard maps and design response spectra specific to the city. This study presented updated probabilistic seismic hazard ground motion for Benghazi city, considering different return periods and accounting for peak ground acceleration (PGA) values with various soil conditions. Proposed design response spectra for Benghazi City unveil substantial PGA amplifications in soft soil areas.
Zitieren
APA
Layas, F. M., Karakale, V., & Suleiman, R. E. (2024). Developing design response spectra for Benghazi city including soil magnification effects. Building Engineering. https://doi.org/10.59400/be.v2i1.1190
Vancouver
Layas FM, Karakale V, Suleiman RE. Developing design response spectra for Benghazi city including soil magnification effects. Building Engineering. 2024. doi:10.59400/be.v2i1.1190
BibTeX
@article{Layas2024,
author = {Layas, Fathi M. and Karakale, Vail and Suleiman, Ramadan E.},
title = {Developing design response spectra for Benghazi city including soil magnification effects},
journal = {Building Engineering},
year = {2024},
doi = {10.59400/be.v2i1.1190}
}
EUVIMED